Seventh International Symposium on Pertussis: Genome, Pathogenesis, and Immunity
September 18-22, 2002
Hinxton, United Kingdom

After a 12-year hiatus, a series of meetings on pertussis was renewed with the Seventh International Symposium on Pertussis: Genome, Pathogenesis and Immunity, held September 18-22, 2002, at the Wellcome Trust Genome Centre near Cambridge England. The meeting was jointly sponsored by the Wellcome Trust and the American Society for Microbiology.

In order to further foster the discussions started at the meeting, the following items were created.  First, a web board has been made available so that attendees, as well as others in the Pertussis community, could post discussion topics on the web. Also, some of the presentations have been provided below for an enduring reference of information presented at the meeting.

WEB BOARD

To access the web board, please click the link below.  You will be required to create a user name and password.  This user name will allow you to read questions/comments and to post your own.  

Pertussis Web Board

ENDURING MATERIALS

Speakers and poster presenters from the 7th International Symposium on Pertussis were asked to provide some of their materials for posting.  Please click on the hyperlinks below to see their materials.  The files should be opened using Adobe Reader 5.0.  

Invited Speakers:

Pertussis Toxin Promotes Th1 Responses in Human Monocytes-derived DC: Relevance in the Protection by Pertussis Vaccines
C. Ausiello

Target Host Cells of Bordetella pertussis
P. Gueirard

Adenylate Cyclase Toxin: Who's Doing What to Whom
E. Hewlett

Variability of Bordetella Strains and Potential Impact on Vaccine Efficacy
G. Sanden

Poster Presentations:

Pertussis Outbreak in a General Hospital
L. Bassinet

Long-Term Serological Follow-Up to Study of Safety and Immunogenicity of One Lot of Tetanus and Diphtheria Toxoids Adsorbed Combined with Three Lots of Component Pertussis (TDCP) Vaccine Compared to Tetanus and Diphtheria Toxoids Adsored (TD) and Component Pertussis (CP) Vaccine Give Seperately in Adults and Adolescents (TC9704)
M. Bologa

Immune Modulation Effect of Active Pertussis Toxin on Cellular Humoral Responses of Acellular Pertussis Vaccine and Protective Activity
C. Canthaboo

French pertussis situation: Epidemiology, vaccine efficacy, evolution of Bordetella pertussis population
V. Caro

Effects of Adsorption of Acellular Pertussis Antigens onto Different Aluminium Salts on the Protective Activity in an Intranasal Murine Model of Bordetella pertussis Infection
P. Denoel

Delivery of Adenylate Cyclase (AC) Toxin from Bordetella pertussis to Host Cells is an Active Process
E. Hewlett

Differential expression (DE) of Bordetella pertussis genes using cDNA microarray
D. Hot

Bordetella Pertussis is Susceptible to the Killing Effects of Nitric Oxide and Oxygen Intermediates
Y. Liu

Current Issues in Pertussis Control by Immunisation In Australia
P. McIntyre

Bap-5, a Newly Identified Member of the Bordetella pertussis Autotransporter Family
R. Parton

Determination of Antibody to Bordetella pertussis Adenylate Cyclase Toxin in the Sera of Children Vaccinated with DTPw or DTPa or in Sera from Children with Pertussis
K. Patel

Considerations for the Use of Recombinant Adenylate Cyclase Toxin Preparations as Multipurpose Vaccines
S. Prior

Aggravated Lung Pathology and Induction of Immediate Hypersensitivity in Mice by a Whole-Cell and an Acellular Pertussis Vaccine
R. Vanderbriel

Changing Pertussis Epidemiology in the United States from 1984 - 2000
G. Wallace

Serotypes of Bordetella pertussis Isolates from German Children Participating in a Pertussis Vaccine Efficacy Trial and from Non-study Participants Living in the Sam Geographic Area
D.K.L. Xing

Determination of Gene Expression in Murine Splenic Cells after Immunisation with Pertussis Vaccines
D.K.L. Xing